VITROS Anti-SARS-CoV-2 IgG Controls for Enhanced Chemiluminescence Immunoassay, Lot 0150

VITROS Anti-SARS-CoV-2 IgG Controls for Enhanced Chemiluminescence Immunoassay, Lot 0150

Introducing the VITROS Anti-SARS-CoV-2 IgG Controls kit designed for the immunodiagnostic detection of IgG antibodies to SARS-CoV-2 using enhanced chemiluminescence on VITROS series analyzers. This kit is supplied under lot number 0150.

Kit Components:

• Control 1 (Negative Control) – 3 vials, each containing 2.0 mL
• Control 2 (Positive Control) – 3 vials, each containing 2.0 mL

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, VITROS Anti-SARS-CoV-2 IgG Controls for Enhanced Chemiluminescence Immunoassay, Lot 0150, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.